SDI

Europe has remained the second largest regional market for analytical and life science instrumentation (after North America) for many years, with steady growth in the low- to mid-single-digit range. Generally speaking, the western part of the continent is made up of highly developed, mature instrument markets, while the eastern part holds strong growth potential. The…

Cell and gene therapy (CGT) is a rapidly evolving field producing powerful new treatments for cancers and genetic diseases, and expanding into autoimmune disease, cardiovascular disease, musculoskeletal disease, and many others. The CGT field has generated great interest and hope among researchers, patient groups, and regulators, which has led to huge investments in R&D. Globally,…

The chemical industry, sandwiched downstream of oil & gas and upstream of pharmaceuticals, foods, and other manufacturing industries, is the backbone of most industrial processes, providing the key raw materials needed for the vast majority of end-use consumer products. Encompassing commodity chemicals, specialty chemicals, and fine chemicals, laboratories within this industry comprise about 5% of…

For most manufacturing facilities in the food industry, laboratories must first test the raw materials that are purchased from an external supplier or farm. This must occur before they are allowed to be processed by the manufacturer. As the raw materials are processed, they are usually tested or monitored in some way. Samples tested during…

Environmental testing is a key area of the global analytical instrumentation market that looks at qualitatively and/or quantitatively analyzing contaminants in the environment. These contaminants can take many forms, from toxic chemicals in drinking water as the result of industrial processes to small particulate matter in the air we breathe. In order to protect from…

The SDi Global Assessment Report 2020: The Laboratory Analytical & Life Science Instrumentation Industry is the gold standard for market research reports in the analytical and life science instrument market.

Updated June 2020 to reflect the COVID-19 and related lab closure situation.

This report provides detailed data on every major life science and analytical instrument technology…

The global demand for biopharmaceuticals is expanding at a rapid pace, as they are more extensively accepted for the clinical treatment of a wide range of ailments. Unlike small molecule drugs, these biomolecule-based therapeutics, or biologics, are produced using living cells in two distinct phases, called upstream and downstream, which necessitates unique manufacturing processes collectively…

Contract research organizations (CROs) are essential partners in the drug development field. As companies in the pharmaceutical and biotechnology industries shift their development pipelines towards more targeted therapies, the cost of development has significantly increased while the patient pool for each drug is smaller. This has resulted in leaner R&D infrastructures and increasing reliance on…